Research programme: serotonin 4 receptor agonists - Predix
Alternative Names: 5-HT4 receptor agonists - PredixLatest Information Update: 21 Aug 2007
At a glance
- Originator Predix Pharmaceuticals
- Class
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Irritable bowel syndrome
Most Recent Events
- 27 Mar 2006 No development reported - Preclinical for Alzheimer's disease in USA (unspecified route)
- 27 Mar 2006 No development reported - Preclinical for Irritable bowel syndrome in USA (unspecified route)
- 13 Feb 2004 Preclinical trials in Alzheimer's disease in USA (unspecified route)